IBXNF logo

IBXNF IBEX Technologies Inc.

Other OTC · Biotechnology · Healthcare

$1.00
-0.07 (-6.54%)

Operating internationally, with key markets spanning Canada, the United States, Germany, and the United Kingdom, IBEX Technologies Inc. focuses on the development and sale of enzymes for various biomedical purposes. Its extensive product catalog includes a range of recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, alongside Chondroitinase AC and B. The company also provides …

Price

No data yet.

Social Signal Score

53
5d
—
30d
55
4 mentions
—
60d
53
6 mentions
—
90d
50
10 mentions
—
news: 10

Revenue

$1.92M+68.56%
$627.4K$1.17M$1.72M$2.26M
Apr 2014Jan 2024

Company Profile

CEO
Paul Baehr
Sector
Healthcare
Industry
Biotechnology
Beta
-0.04
Country
CA
Piotroski score
6 / 9 (Middling)
Altman Z-score
5.64
www.bbisolutions.com/en/reagents/heparinase